FTC to look into drugmakers

Published: 2010-06-23 06:59:00

Updated: 2010-06-23 06:59:00

Korea’s antitrust regulator has embarked on looking into the intellectual property rights of the pharmaceutical industry following its longstanding investigation into the drug makers’ undue business practices such as rebate-offering.

The Fair Trade Commission (FTC) said on June 21 that the bus...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK